CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
0.867
-0.004 (-0.41%)
At close: Nov 21, 2024, 4:00 PM
0.885
+0.018 (2.14%)
After-hours: Nov 21, 2024, 7:12 PM EST
CytomX Therapeutics Employees
As of December 31, 2023, CytomX Therapeutics had 122 total employees, including 120 full-time and 2 part-time employees. The number of employees increased by 4 or 3.39% compared to the previous year.
Employees
122
Change (1Y)
4
Growth (1Y)
3.39%
Revenue / Employee
$1,037,844
Profits / Employee
$113,361
Market Cap
67.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Armata Pharmaceuticals | 66 |
Aligos Therapeutics | 66 |
InspireMD | 66 |
BioAtla | 65 |
Vivani Medical | 44 |
Vistagen Therapeutics | 40 |
Modular Medical | 40 |
BeyondSpring | 36 |
CTMX News
- 13 days ago - CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors - GlobeNewsWire
- 3 months ago - CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - GlobeNewsWire
- 5 months ago - CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer - GlobeNewsWire
- 6 months ago - CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - CytomX Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire